Target Name: DAG1
NCBI ID: G1605
Review Report on DAG1 Target / Biomarker Content of Review Report on DAG1 Target / Biomarker
DAG1
Other Name(s): beta-DG_(HUMAN) | Alpha-DG | Dystroglycan 1, transcript variant 1 | A3a | A-DG | dystroglycan 1 | dystroglycan 1 (dystrophin-associated glycoprotein 1) | Beta-dystroglycan | DAG | Dystroglycan 1, transcript variant 2 | Dystroglycan 1 preproprotein | Dystroglycan 1 | Dystrophin-associated glycoprotein-1 | DAG1 variant 1 | DAG1 variant 2 | AGRNR | 156DAG | MDDGA9 | MDDGC9 | Beta-DG | alpha-DG_(HUMAN) | beta-DG | LGMDR16 | MDDGC7 | Dystrophin-associated glycoprotein 1 | DAG1_HUMAN | Alpha-dystroglycan | Dystroglycan

DAG1: Drug and Radiation Detoxification, Cell Growth, Differentiation, Inflammation and Brain Barrier Regulation

DAG1 (beta-DG_(HUMAN)) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and heart. It is a key player in the detoxification of harmful substances and has been linked to a number of important cellular processes.

One of the most significant functions of DAG1 is its role in the detoxification of drugs, such as methamphetamine and polychlorinated biphenyls (PCBs). These substances are known to be toxic to the brain and have been linked to a number of serious health problems, including cancer, neurodegenerative diseases, and reproductive problems.

DAG1 is also involved in the detoxification of other harmful substances, including environmental toxins and industrial chemicals. It has been shown to be effective in reducing the levels of these substances in the body and may have potential as a drug target for treating a number of diseases.

In addition to its role in detoxification, DAG1 is also involved in a number of other important cellular processes. It is a signaling molecule that is involved in the regulation of cell growth, differentiation, and death. It is also involved in the production of reactive oxygen species (ROS), which can damage cells and contribute to a number of diseases.

DAG1 has also been shown to be involved in the regulation of inflammation. It is a source of reactive oxygen species (ROS) and has been shown to contribute to the production of ROS in the body. This may have implications for the development of inflammatory diseases.

DAG1 is also involved in the regulation of the blood-brain barrier. This barrier helps to protect the brain from harmful substances and is critical for the development and maintenance of brain health.

In conclusion, DAG1 (beta-DG_(HUMAN)) is a protein that is expressed in various tissues throughout the body and is involved in a number of important cellular processes. Its role in detoxification and inflammation may make it a potential drug target for the treatment of a number of diseases. Further research is needed to fully understand the functions of DAG1 and its potential as a drug.

Protein Name: Dystroglycan 1

Functions: The dystroglycan complex is involved in a number of processes including laminin and basement membrane assembly, sarcolemmal stability, cell survival, peripheral nerve myelination, nodal structure, cell migration, and epithelial polarization

The "DAG1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DAG1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

DAGLA | DAGLB | DALRD3 | DANCR | DAND5 | DANT2 | DAO | DAOA | DAOA-AS1 | DAP | DAP3 | DAPK1 | DAPK1-IT1 | DAPK2 | DAPK3 | DAPL1 | DAPP1 | DARS1 | DARS1-AS1 | DARS2 | DAW1 | DAXX | DAZ1 | DAZ2 | DAZ3 | DAZ4 | DAZAP1 | DAZAP2 | DAZAP2P1 | DAZL | DBET | DBF4 | DBF4B | DBF4P1 | DBH | DBH-AS1 | DBI | DBIL5P | DBIL5P2 | DBIP2 | DBIRD complex | DBN1 | DBNDD1 | DBNDD2 | DBNL | DBP | DBR1 | DBT | DBX1 | DBX2 | DCAF1 | DCAF10 | DCAF11 | DCAF12 | DCAF12L1 | DCAF12L2 | DCAF13 | DCAF13P3 | DCAF15 | DCAF16 | DCAF17 | DCAF4 | DCAF4L1 | DCAF4L2 | DCAF5 | DCAF6 | DCAF7 | DCAF8 | DCAF8L1 | DCAF8L2 | DCAKD | DCANP1 | DCBLD1 | DCBLD2 | DCC | DCD | DCDC1 | DCDC2 | DCDC2B | DCDC2C | DCHS1 | DCHS2 | DCK | DCLK1 | DCLK2 | DCLK3 | DCLRE1A | DCLRE1B | DCLRE1C | DCN | DCP1A | DCP1B | DCP2 | DCPS | DCST1 | DCST1-AS1 | DCST2 | DCSTAMP | DCT | DCTD